Literature DB >> 9224967

Determination of the N- and C-terminal sequences required to bind human IgE of the major house dust mite allergen Der f 2 and epitope mapping for monoclonal antibodies.

T Takai1, T Yuuki, Y Okumura, A Mori, H Okudaira.   

Abstract

B cell epitopes of the major house dust mite allergen Der f 2 from Dermatophagoides farinae were analysed using deletion mutants of Der f 2 expressed as fusion proteins in Escherichia coli. The reactivities of these partial Der f 2 molecules to human anti-mite IgE antibodies in atopic patients and to murine anti-Der f2 monoclonal antibodies (mAbs) were examined by immunoblotting. A C-terminal deletion mutant of Der f 2, 1-123, had almost the same reactivity to human IgE as the whole Der f 2 (1-129) and an N-terminal deletion mutant of Der f 2 (25-129) still had weak reactivity. On the other hand, in two deleted Der f 2 molecules, 1-120 and 30-129, reactivity was lost in spite of long overlapping sequences. These results suggest that the human IgE antibodies to Der f 2 in atopic patient sera recognize the conformational structures dependent on the tertiary structure of Der f 2, including disulfide bond formations, rather than the contiguous sequences of amino acids. The sequences 1-24, 25-29 and 121-123 were revealed as the minimum N- and C- terminal amino acid sequences required for IgE binding. Contrastingly, all three murine mAbs bound to the smaller deletion mutants, 1-90 and 67-129, suggesting that the cores of the epitopes for these mAbs exist in the 24 amino acid sequence of Der f 2, 67-90 overlapping the sequential human IgE epitope on Der p 2, the equivalent allergen from Dermatophagoides pteronyssinus. These findings are important for the understanding of the antigenic structure of Der f 2 and for the manipulation of the allergen for immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224967     DOI: 10.1016/s0161-5890(97)00020-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Prevention and treatment of allergic inflammation by an Fcγ-Der f2 fusion protein in a murine model of dust mite-induced asthma.

Authors:  Li-hui Lin; Ping Zheng; John W M Yuen; Juan Wang; Juan Zhou; Cun-quan Kong; Xia Peng; Jia Li; Li Li
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Immunoglobulin E-binding epitopes of mite allergens: from characterization to immunotherapy.

Authors:  Yubao Cui
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

3.  Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.

Authors:  K-W Chen; M Focke-Tejkl; K Blatt; M Kneidinger; A Gieras; F Dall'Antonia; I Faé; G Fischer; W Keller; P Valent; R Valenta; S Vrtala
Journal:  Allergy       Date:  2012-02-17       Impact factor: 13.146

Review 4.  Genetically engineered vaccines.

Authors:  Wayne R Thomas; Belinda J Hales; Wendy-Anne Smith
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.